Rocket


News + Filings
Transactions





O'Neill Gilmore Neil

DateNameSymbolTypeSecuritySharesPriceValueOwnershipReported
06/05/2023Editas Medicine, Inc.EDITSaleCommon Stock6.5k$9.50$61.6k 06/05/2023
03/02/2023Editas Medicine, Inc.EDITGrantStock Option (right to buy)150k$8.72$1.3M 03/02/2023
03/02/2023Editas Medicine, Inc.EDITGrant 50k$0.00$0 03/02/2023
06/24/2022Unity Biotechnology, Inc.UBXGrantStock Option (Right to Buy)25k$0.59$14.8k 06/24/2022
06/02/2022Editas Medicine, Inc.EDITGrantStock Option (right to buy)950.2k$11.54$11M 06/02/2022
06/02/2022Editas Medicine, Inc.EDITGrant 86.7k$0.00$0 06/02/2022
05/26/2022Aptinyx Inc.APTXGrantStock Option (Right to Buy)40k$0.50$20k 05/26/2022
10/19/2021Aptinyx Inc.APTXGrantStock Option (Right to Buy)80k$2.26$180.8k 10/19/2021
06/24/2021Unity Biotechnology, Inc.UBXGrantStock Option (Right to Buy)13.4k$4.18$56.1k 06/24/2021
03/03/2021Sarepta Therapeutics, Inc.SRPTGrantStock Option (right to buy)60k$87.11$5.2M 03/03/2021
03/03/2021Sarepta Therapeutics, Inc.SRPTGrantCommon Stock15k$0.00$0 03/03/2021
03/03/2021Sarepta Therapeutics, Inc.SRPTGrantCommon Stock15k$0.00$0 02/28/2021
02/28/2021Sarepta Therapeutics, Inc.SRPTPayment of ExerciseCommon Stock524$86.97$45.6k 02/28/2021
12/10/2020Unity Biotechnology, Inc.UBXGrantStock Option (Right to Buy)50k$6.12$306k 12/10/2020
02/28/2020Sarepta Therapeutics, Inc.SRPTGrantCommon Stock6.7k$0.00$0 02/28/2020
02/28/2020Sarepta Therapeutics, Inc.SRPTGrantStock option (right to buy)37.5k$114.47$4.3M 02/28/2020
05/24/2019Sarepta Therapeutics, Inc.SRPTPayment of ExerciseCommon Stock4.6k$119.31$552.4k 05/23/2019
05/23/2019Sarepta Therapeutics, Inc.SRPTExerciseRestricted Stock Units12k$0.00$0 05/23/2019
03/04/2019Sarepta Therapeutics, Inc.SRPTGrantStock option (right to buy)55k$145.48$8M 03/04/2019
06/07/2018Sarepta Therapeutics, Inc.SRPTGrantRestricted Stock Units12k$0.00$0 06/07/2018
06/07/2018Sarepta Therapeutics, Inc.SRPTGrantStock option (right to buy)100k$96.23$9.6M 06/07/2018

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy